How have ALEC and GALT total returns compared?

Over the past 5 years, ALEC delivered -39.17% and GALT delivered 0.60% annualized total return. Past performance doesn't predict future results.

Alector, Inc. (ALEC) vs Galectin Therapeutics Inc. (GALT)

A side-by-side comparison of Alector, Inc. and Galectin Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ALEC

Alector, Inc.

$213M

$1.92HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT

GALT

Galectin Therapeutics Inc.

$242M

$3.67HealthcareDelayed quote: Oct 6, 2026, 10:04 AM EDT

Total return — ALEC vs GALT

growth of $100 · dividends reinvested · last 8y

ALEC -88.9% (-24.1%/yr)GALT -22.9% (-3.2%/yr)GALT compounded faster over this window

Log scale — wide-divergence pair

ALEC GALT

ALEC vs GALT: by the numbers

•GALT is the larger company ($242M vs $213M market cap).
•Both run net losses; GALT's is the smaller (0.00% vs -850.13% net margin).

Metrics side by side

Valuation

Metric	ALEC	GALT
P/S ratio	15.38	N/A

Profitability

Metric	ALEC	GALT
Gross margin	54.09%	0.00%
Operating margin	-692.83%	0.00%
Net margin	-850.13%	0.00%
ROIC	-71.04%	-1718.59%

Growth (annualized)

Metric	ALEC	GALT
Revenue CAGR (5Y)	-8.35%	N/A
Total return CAGR (5Y)	-39.17%	0.60%

Frequently asked

How have ALEC and GALT total returns compared?: Over the past 5 years, ALEC delivered -39.17% and GALT delivered 0.60% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ALEC analysis Full GALT analysis Interactive comparison tool

Dig into the metrics

Alector ROE Galectin Therapeutics ROE Alector operating margin Galectin Therapeutics operating margin Alector revenue growth Galectin Therapeutics revenue growth Alector free cash flow Galectin Therapeutics free cash flow

Alector & Galectin Therapeutics appear in these rankings

Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.